GOLDILOX (Completed)
A Phase IIB, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction, Persistent Inflammation, and Elevated N-terminal Prohormone Brain Natriuretic Peptide
- Medicine
- MEDI6570
- Population
- ASCVD
- Phase
- IIB
- Starting year
- 2020